Wednesday, November 22, 2017 4:11:09 AM
CUSIP: 90916J
Auth
orized shares of Common Stock:
9
00,000,000
Common shares iss
ued and outstanding: 284,309,092
Shares in the public float: Approximately 207,348,941
Number of s
hareholders:
Approximately 2,395
Number of "free
-
trading": 207,348,941
Authorized shares of Preferred Stock: 50,000,000
Preferred shares issued and outstanding: 22,950,000
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM